Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Seizures in Neonate With Hypoxic Ischemic Encephalopathy
NCT07284498Phase 4Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2026
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levetiracetam in seizure, hypoxic-ischemic encephalopathy (HIE), sponsored by Mansoura University. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
seizurehypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT07284498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07284498.